Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-213X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma ; volume:11 ; number:1 ; day:3 ; month:1 ; year:2011 ; pages:1-11 ; date:12.2011
BMC developmental biology ; 11, Heft 1 (3.1.2011), 1-11, 12.2011
- Creator
-
Henriksen, Jørn R.
Haug, Bjørn Helge
Buechner, Jochen
Tømte, Ellen
Løkke, Cecilie
Flaegstad, Trond
Einvik, Christer
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-213X-11-1
- URN
-
urn:nbn:de:101:1-2021081510013979281319
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Henriksen, Jørn R.
- Haug, Bjørn Helge
- Buechner, Jochen
- Tømte, Ellen
- Løkke, Cecilie
- Flaegstad, Trond
- Einvik, Christer
- SpringerLink (Online service)
Other Objects (12)
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma